DrugDashboards

Esomeprazole Magnesium for delayed-release oral suspension

Esomeprazole Magnesium · ESOMEPRAZOLE MAGNESIUM 10 mg/1 · Granule, Delayed Release · Oral · Torrent Pharmaceuticals Limited

NDC 13668-0548-94 · 30 GRANULE, DELAYED RELEASE in 1 CARTON · ANDA · View full market →

The short version

5 companies supply this market — a reasonable cushion if one runs into trouble. The generic price is down 24% over the past year, to $5.23 per unit. The brand (Nexium) runs $9.14 per unit — 2× more. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$5.23per EAinvoice-surveyed acquisition cost · Aug 19, 2026
  • Part D plans paid (avg)$0.6399per dosage unitgross, before rebates — matched by drug name · 2024

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$2.50$5.00$7.50Apr 2025Sep 2026$5.23
17 price points · per EASource: CMS NADAC

Estimated fill cost

WAC per package, as filed
$210.73
Reported to Texas DSHS · 2026 annual filing · Torrent Pharmaceuticals

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2025)

$288,618
1,395 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

13● Low risk

Some pressure is visible, but not much — here’s everything the score found to count.

  • 5 active manufacturers+5
  • price down 23% year over year+8

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for esomeprazole magnesium (other) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA212652
TE code
AB
Approval date
Mar 5, 2025
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Esomeprazole Magnesium (Granule, Delayed Release)

LabelerStrengthFirst seenLast seen
AstraZeneca Pharmaceuticals LPESOMEPRAZOLE MAGNESIUM TRIHYDRATE 10 mg/1Jul 15, 2026Sep 2, 2026
AstraZeneca Pharmaceuticals LPESOMEPRAZOLE MAGNESIUM TRIHYDRATE 5 mg/1Jul 15, 2026Sep 2, 2026
AstraZeneca Pharmaceuticals LPESOMEPRAZOLE MAGNESIUM TRIHYDRATE 40 mg/1Jul 15, 2026Sep 2, 2026
AstraZeneca Pharmaceuticals LPESOMEPRAZOLE MAGNESIUM TRIHYDRATE 20 mg/1Jul 15, 2026Sep 2, 2026
AstraZeneca Pharmaceuticals LPESOMEPRAZOLE MAGNESIUM TRIHYDRATE 2.5 mg/1Jul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedESOMEPRAZOLE MAGNESIUM TRIHYDRATE 5 mg/1Jul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedESOMEPRAZOLE MAGNESIUM TRIHYDRATE 10 mg/1Jul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedESOMEPRAZOLE MAGNESIUM TRIHYDRATE 20 mg/1Jul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedESOMEPRAZOLE MAGNESIUM TRIHYDRATE 40 mg/1Jul 15, 2026Sep 2, 2026
Torrent Pharmaceuticals LimitedESOMEPRAZOLE MAGNESIUM 20 mg/1Jul 15, 2026Sep 2, 2026
Torrent Pharmaceuticals LimitedESOMEPRAZOLE MAGNESIUM 10 mg/1Jul 15, 2026Sep 2, 2026
Torrent Pharmaceuticals LimitedESOMEPRAZOLE MAGNESIUM 5 mg/1Jul 15, 2026Sep 2, 2026
Torrent Pharmaceuticals LimitedESOMEPRAZOLE MAGNESIUM 40 mg/1Jul 15, 2026Sep 2, 2026
Torrent Pharmaceuticals LimitedESOMEPRAZOLE MAGNESIUM 2.5 mg/1Jul 15, 2026Sep 2, 2026
Zydus Lifesciences LimitedESOMEPRAZOLE MAGNESIUM DIHYDRATE 20 mg/1Jul 15, 2026Sep 2, 2026
Zydus Lifesciences LimitedESOMEPRAZOLE MAGNESIUM DIHYDRATE 40 mg/1Jul 15, 2026Sep 2, 2026
Zydus Pharmaceuticals USA Inc.ESOMEPRAZOLE MAGNESIUM DIHYDRATE 40 mg/1Jul 15, 2026Sep 2, 2026
Zydus Pharmaceuticals USA Inc.ESOMEPRAZOLE MAGNESIUM DIHYDRATE 20 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Esomeprazole Magnesium for delayed-release oral suspension — NDC 13668-0548-94," retrieved September 3, 2026, https://drugdashboards.com/drug/13668054894.

Free to cite with attribution — see how the data is put together.